Archives for Uncategorized

Big Pharma Two, Patients Zero: Latest Xarelto Suits

Big Pharma Two, Patients Zero: Latest Xarelto Suits Last week, Big Pharma giants Bayer and Johnson & Johnson scored a victory in the second bellwether trial involving the popular blood thinning drug, Xarelto. A federal jury in New Orleans handed down the verdict clearing the companies of all liability for Sharyn Orr’s 2015 death. The suit, brought by Orr’s husband and children, alleged that Mrs. Orr’s stroke and subsequent death were a result of the medication’s bleeding risks. Such risks, the family claimed, could have been avoided if only Mrs. Orr’s doctor had been given adequate information on the bleeding
Read More

Third-party financing of litigation is a crime in Pennsylvania

Bayer, J&J Win 2nd Xarelto Trial Last month, drug manufacturers Johnson & Johnson and Bayer Pharmaceuticals filed a motion in Philadelphia County Court of Common Pleas to compel plaintiff counsel to disclose whether their litigation against the makers of Xarelto is being financed by outside interests. They want to know if any third party “has the right to control or be consulted about the plaintiffs’ litigation and whether there is a third-party source of funding for the plaintiffs’ litigation,” in addition to seeking the identities of any such funders and production of documents detailing any agreements involving same. It’s not
Read More

Bayer, J&J Win 2nd Xarelto Trial

Bayer, J&J Win 2nd Xarelto Trial The second bellwether trial over the safety of the blood thinner Xarelto has ended with a second verdict in favor of drug makers Bayer and Johnson & Johnson. The trial in federal court in New Orleans involved the family of Sharyn Orr, who died in May 2015 at the age of 67 following a hemorrhagic stroke about a year after she started taking Xarelto for atrial fibrillation. Before she died, Orr was in a coma for 10 days. Her family’s lawyer contended her death was “completely avoidable.” The drug companies argued that Orr had
Read More

Widower, family face off against J&J and Bayer in next Xarelto bleeding-risk case

Widower, family face off against J&J and Bayer in next Xarelto bleeding-risk case Janssen and Bayer are in court again defending Xarelto against claims it caused a patient’s death. It wasn’t long ago that Johnson & Johnson and Bayer came up victorious in the first bellwether trial over Xarelto’s bleeding risks. Now, they’re in court again defending the big-selling blood thinner against claims it caused a patient’s death. Plaintiffs in the new case are the widower and children of Sharyn M. Orr, a grandmother who died in May 2015 at the age of 67 after suffering a brain hemorrhage. In
Read More

Study Shows Xarelto Has Higher Bleeding Rates than Competitors

Study Shows Xarelto Has Higher Bleeding Rates than Competitors In a recently published study, researchers who examined the effects of the three anticoagulants Xarelto, Eliquis, and Pradaxa conclude that Xarelto was associated with more incidents of gastrointestinal bleeding than the other two. All three of the drugs, however, were associated with increased GI bleeding. The drugs are all direct oral anticoagulant (DOAC) agents, relatively new, and intended to take the place of warfarin, the most prevalently prescribed blood thinner. The study was conducted by the Mayo Clinic and published in the medical journal Gastroenterology. It examines data from roughly 57,000
Read More

Did Xarelto Drug Companies Hide Information?

Did Xarelto Drug Companies Hide Information? The makers of Xarelto face accusations from plaintiffs’ attorneys that they hid information from editors at The New England Journal of Medicine. The New York Times (3/1/16) published an article reporting that a letter, which was written by researchers at Duke University and published by The New England Journal of Medicine, left out vital laboratory data. Lawyers involved in Xarelto lawsuits say that information may have misled editors as to Xarelto’s safety and/or effectiveness. Xarelto: Did Drugmakers Hide Information?The letter was published in February, and involved the Alere INRatio Monitor System. That system was
Read More

California Woman Seeks $10 Million in Xarelto Lawsuit

California Woman Seeks $10 Million in Xarelto Lawsuit Shirley and James Boynton filed a new Xarelto lawsuit against manufacturers Janssen Pharmaceuticals; parent company, Johnson and Johnson (J&J); and Bayer Healthcare Pharmaceuticals. The lawsuit is pending in the U.S. District Court for the Eastern District of New York. According to the complaint, the defendants were negligent in failing to provide adequate warnings about the potential side effects associated with Xarelto, a blood-thinning medication used to reduce the risk of stroke in patients with non-valvular atrial fibrillation. The plaintiffs seek $10 million in damages. Plaintiff Blames Xarelto for Hemorrhaging Shirley Boynton is
Read More

Xarelto May Cause More Bleeding Than Pradaxa

Xarelto May Cause More Bleeding Than Pradaxa According to an observational study published in JAMA Internal Medicine, people taking Xarelto (rivaroxaban) may be more likely to have a serious bleeding event than those taking Pradaxa (dabigatran). Johnson and Johnson (J&J) is facing more the 15,000 Xarelto lawsuits. The Study For the study, researchers looked at the records of 118,000 Medicare patients with atrial fibrillation (AFib), who took either Xarelto or Pradaxa. Researchers found that there were more serious bleeding events in those taking Xarelto than those taking Pradaxa. This included intracranial hemorrhage, meaning bleeding in the brain, and extracranial bleeding
Read More

First Xarelto Lawsuit Of Thousands Begins In Louisiana

First Xarelto Lawsuit Bellwether Trial Started in New Orleans It’s official – the first bellwether trial regarding the blood thinner Xarelto started at the end of April in a courtroom in New Orleans, LA. First Plaintiff Bravely Takes The Stand The first plaintiff of thousands who have filed against Bayer Inc and Johnson & Johnson, the manufacturers of Xarelto, filed a lawsuit because he believes that he was harmed by the drug. In his complaint, he alleged that after taking the drug for less than 30 days, he developed serious GI bleeding which doctors were only able to stop after
Read More

The Dirty Secret Behind the Thousands of Xarelto Lawsuits

The Dirty Secret Behind the Thousands of Xarelto Lawsuits Welcome to the circus, boys and girls. Parades, animals, acrobats, clowns, all colluding to approve lethal drugs for public use! Watch people take the drugs and fall down, watch them carted off in colorful cars to hospitals, where the doctors will have no idea what’s causing the life-threatening injuries! It’s wild, it’s crazy, and it’s brought to you by drug companies and their enablers at the FDA! It’s all covered by insurance. We’ve got cotton candy, popcorn, ice cream for the kiddies, and everybody can get in under the big tent!
Read More